A predominantly left upper limb sensory neuronopathy as a manifestation of a metastatic neuroendocrine malignancy

Journal of Clinical Neuroscience - Tập 16 - Trang 838-839 - 2009
A. Lim1, A. Scriven1, W. Knezevic1, M. Texler2
1Department of Neurology, Fremantle Hospital, Alma Street, Fremantle, Western Australia 6160, Australia
2Department of Pathology, Fremantle Hospital, Fremantle, Western Australia, Australia

Tài liệu tham khảo

Rudnicki, 2000, Paraneoplastic syndromes of the spinal cord, nerve, and muscle, Muscle Nerve, 23, 1800, 10.1002/1097-4598(200012)23:12<1800::AID-MUS3>3.0.CO;2-X Chalk, 1992, The distinctive clinical features of paraneoplastic sensory neuronopathy, Can J Neurol Sci, 19, 346, 10.1017/S0317167100041974 Dalmau J, Graus F, Rosenblum MK, et al. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) 1992;71:59. Denny-Brown, 1948, Primary sensory neuropathy with muscular changes associated with carcinoma, J Neurol Neurosurg Psychiatry, 11, 73, 10.1136/jnnp.11.2.73 Mori, 2005, The wide spectrum of clinical manifestations in Sjogren’s syndrome-associated neuropathy, Brain, 128, 2518, 10.1093/brain/awh605 Rees, 2001, The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders, Brain, 124, 2223, 10.1093/brain/124.11.2223 Younes-Mhenni, 2004, FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes, Brain, 127, 2331, 10.1093/brain/awh247 Linke, 2008, FDG-PET in paraneoplastic syndromes, Recent Results Cancer Res, 170, 203, 10.1007/978-3-540-31203-1_16 Ordóñez, 2000, Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas, Adv Anat Pathol, 7, 123, 10.1097/00125480-200007020-00007 Travis, 2004, Small cell carcinoma, 31 Rosenfeld, 2003, Current therapies for paraneoplastic neurologic syndromes, Curr Treat Options Neurol, 5, 69, 10.1007/s11940-003-0023-y Keime-Guibert, 2000, Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone, J Neurol Neurosurg Psychiatry, 68, 479, 10.1136/jnnp.68.4.479 Vernino, 2004, Immunomodulatory treatment trial for paraneoplastic neurological disorders, Neuro-oncol, 6, 55, 10.1215/S1152851703000395 Drlicek, 2000, T cell-mediated paraneoplastic ganglionitis – an autopsy case, Acta Neuropathol, 99, 599, 10.1007/s004010051168